Superbrewed Food Launches Shelf-Stable Thryvia Postbiotic
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
New Castle, Delaware, August 19, 2026 Superbrewed Food, Inc. has announced the commercial launch of Thryvia™, a shelf-stable, protein-derived...
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
OVERLAND PARK, Kan., and BOULDER, Colo., May 12, 2026 Hill’s Pet Nutrition and Bond Pet Foods have announced a...
New Report Maps How AI Prioritizes Pet Nutrition – February 18, 2026 | United States A new analytical report...
